InsiderClue
Stocks · Technology · Laboratory Analytical Instruments

10x Genomics, Inc.

TXG Clue Score54
United States Fiscal year ends December CIK 0001770787 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

16
Insider
Date
Role
Action
Shares
Price
Amount
John R Stuelpnagel
3 Sep 2026
Director
Sell
6,174
$62.61
$386.53K
John R Stuelpnagel
3 Sep 2026
Director
Sell
6,814
$62.11
$423.21K
John R Stuelpnagel
3 Sep 2026
Director
Sell
7,012
$60.66
$425.33K
Benjamin J. Hindson
24 Aug 2026
See Remarks
Sell
13,818
$63.02
$870.86K
Adam Taich
24 Aug 2026
Chief Financial Officer
Sell
17,166
$63.02
$1.08M
Serge Saxonov
24 Aug 2026
Chief Executive Officer
Sell
18,545
$63.02
$1.17M
John R Stuelpnagel
11 Aug 2026
Director
Sell
3,000
$58.73
$176.18K
John R Stuelpnagel
11 Aug 2026
Director
Sell
17,000
$57.58
$978.88K
Adam Taich
22 May 2026
Chief Financial Officer
Sell
15,098
$24.44
$369.02K
Benjamin J. Hindson
22 May 2026
See Remarks
Sell
11,595
$24.44
$283.40K
Benjamin J. Hindson
23 Feb 2026
See Remarks
Sell
7,826
$18.58
$145.38K
Adam Taich
23 Feb 2026
Chief Financial Officer
Sell
8,968
$18.58
$166.59K
Serge Saxonov
23 Feb 2026
Chief Executive Officer
Sell
9,632
$18.58
$178.93K
Serge Saxonov
24 Nov 2025
Chief Executive Officer
Sell
13,261
$19.00
$251.94K
Benjamin J. Hindson
24 Nov 2025
See Remarks
Sell
8,283
$19.00
$157.36K
Adam Taich
24 Nov 2025
Chief Financial Officer
Sell
11,888
$19.00
$225.85K
Show all 51 transactions →

What was left out

Form 4 filings counted 38
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 34
Sales straight out of an exercise 0
Sales at will 16
Transactions with no price 0
Shares from compensation/vesting 463,114
History held since 12 Sep 2019